Raphaelle Richieri

This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article...

Medication nonadherence among schizophrenia patients is common, but also possibly modifiable. Learn about how a patient self-report instrument—the MARS—can be used to identify nonadherence in these patients.